Display options
Cite
Oluwasola A, Otegbayo J, Ola S, et al. Correlation of serum anti-helicobacter pylori immunoglobulin a (IgA) with histological parameters of chronic gastritis in ibadan, Nigeria. Ann Ib Postgrad Med. 2012;10(1):18-24
Oluwasola, A., Otegbayo, J., Ola, S., Ebili, H., Afolabi, A., & Odaibo, G. (2012). Correlation of serum anti-helicobacter pylori immunoglobulin a (IgA) with histological parameters of chronic gastritis in ibadan, Nigeria. Annals of Ibadan postgraduate medicine, 10(1), 18-24.
Oluwasola, Ao, et al. "Correlation of serum anti-helicobacter pylori immunoglobulin a (IgA) with histological parameters of chronic gastritis in ibadan, Nigeria." Annals of Ibadan postgraduate medicine vol. 10,1 (2012): 18-24.
Oluwasola A, Otegbayo J, Ola S, Ebili H, Afolabi A, Odaibo G. Correlation of serum anti-helicobacter pylori immunoglobulin a (IgA) with histological parameters of chronic gastritis in ibadan, Nigeria. Ann Ib Postgrad Med. 2012 Jun;10(1):18-24. PMID: 25161402; PMCID: PMC4111042.
Copy Download .nbib Format: NLM
Share it on

Ann Ib Postgrad Med. 2012 Jun;10(1):18-24.

Correlation of serum anti-helicobacter pylori immunoglobulin a (IgA) with histological parameters of chronic gastritis in ibadan, Nigeria.

Annals of Ibadan postgraduate medicine

Ao Oluwasola, Ja Otegbayo, So Ola, Ho Ebili, Ao Afolabi, Gn Odaibo

Affiliations

  1. Department of Pathology, University College Hospital, Ibadan, Nigeria.
  2. Department of Medicine, University College Hospital, Ibadan, Nigeria.
  3. Department of Surgery, University College Hospital, Ibadan, Nigeria.
  4. Department of Virology, University College Hospital, Ibadan, Nigeria.

PMID: 25161402 PMCID: PMC4111042

Abstract

BACKGROUND: The seroprevalence of anti-H. pylori IgA antibodies has been reported to vary among populations and in relation to strains of Helicobacter pylori bacterium. However, there has been conflicting reports on the association between IgA serological status and the histological variables of chronic gastritis. This study was therefore conducted to clarify this relationship.

METHOD: Using an ELISA based commercial kit, anti-H. pylori IgA antibody tests were performed on 65 dyspeptic patients and 65 age- and sex-matched controls. The gastric biopsies of these patients were also examined histologically for the degrees of inflammation, activity, intestinal metaplasia and atrophy. The CagA status of the patients had been determined previously.

RESULTS: There was an anti-H. pylori IgA antibody prevalence of 67.7% in dyspeptics and 56.9% in non-dyspeptic individuals. No correlations were observed between serum H. pylori IgA antibody and the graded parameters of chronic gastritis in dyspeptic patients, although twice more patients with mild gastric inflammation were found among IgA positive than among IgA negative patients. However, a statistically significant relationship was established between serum IgA positivity and the CagA status of the patients (p = 0.028).

CONCLUSION: The seroprevalence of anti-H. pylori IgA antibody is high in our environment. Serum IgA status may be associated with milder degrees of gastritis in our patients but a larger cohort of patients is needed to confirm this. There seems to be a good agreement between serum IgA and CagA statuses among dyspeptic patients.

References

  1. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8796-800 - PubMed
  2. Gastroenterology. 1992 Feb;102(2):720-7 - PubMed
  3. J Clin Pathol. 1994 Mar;47(3):227-31 - PubMed
  4. J Exp Med. 1992 Feb 1;175(2):517-25 - PubMed
  5. J Infect Dis. 2003 Jul 15;188(2):272-81 - PubMed
  6. Am J Gastroenterol. 1992 Jan;87(1):28-30 - PubMed
  7. Lab Invest. 1995 Dec;73(6):760-70 - PubMed
  8. J Med Microbiol. 1988 Jun;26(2):93-9 - PubMed
  9. Am J Clin Pathol. 1986 Nov;86(5):575-82 - PubMed
  10. J Clin Microbiol. 1993 Jun;31(6):1450-3 - PubMed
  11. Clin Diagn Lab Immunol. 1994 May;1(3):325-9 - PubMed
  12. Gastroenterology. 2002 Jul;123(1):92-105 - PubMed
  13. J Infect Dis. 1989 Mar;159(3):586-9 - PubMed
  14. J Immunol. 2005 Jun 15;174(12):8144-53 - PubMed
  15. Immunol Today. 1993 Sep;14(9):430-5 - PubMed
  16. J Natl Cancer Inst. 1995 Dec 6;87(23):1777-80 - PubMed
  17. J Infect Dis. 1990 Apr;161(4):626-33 - PubMed
  18. Infect Immun. 1993 May;61(5):1799-809 - PubMed
  19. Ann Med. 2000 Dec;32(9):652-6 - PubMed
  20. Am J Epidemiol. 1996 Jul 15;144(2):142-9 - PubMed
  21. J Biol Chem. 1990 Jun 5;265(16):9464-9 - PubMed
  22. World J Gastroenterol. 2005 Nov 21;11(43):6871-4 - PubMed
  23. J Immunol. 2000 Jul 15;165(2):1022-9 - PubMed
  24. Infect Immun. 1998 Jun;66(6):2705-12 - PubMed
  25. Gut. 2004 Aug;53(8):1082-9 - PubMed
  26. Gut. 1998 Aug;43(2):168-75 - PubMed
  27. J Clin Gastroenterol. 1995;21 Suppl 1:S164-8 - PubMed
  28. Infect Immun. 1992 May;60(5):1946-51 - PubMed
  29. Gastroenterology. 2003 Aug;125(2):364-71 - PubMed
  30. Gut. 1986 Jun;27(6):642-7 - PubMed
  31. Nihon Shokakibyo Gakkai Zasshi. 1994 Dec;91(12):2202-13 - PubMed
  32. Infect Immun. 1993 May;61(5):1601-10 - PubMed
  33. J Clin Invest. 1991 Mar;87(3):894-900 - PubMed
  34. J Biol Chem. 1992 May 25;267(15):10570-5 - PubMed
  35. Nat Immunol. 2001 Oct;2(10):947-50 - PubMed
  36. Infect Immun. 2000 Aug;68(8):4802-4 - PubMed
  37. Ann Intern Med. 1988 Jul 1;109(1):11-7 - PubMed
  38. Gut. 1982 Jul;23(7):578-88 - PubMed
  39. Lancet. 1992 Apr 11;339(8798):893-5 - PubMed
  40. J Immunol. 2004 Apr 15;172(8):5024-33 - PubMed
  41. Gastroenterology. 2002 Dec;123(6):1793-803 - PubMed
  42. Scand J Gastroenterol. 1991 Oct;26(10):1057-65 - PubMed
  43. World J Gastroenterol. 2003 Apr;9(4):755-8 - PubMed
  44. Gut. 2000 Apr;46(4):460-3 - PubMed
  45. Clin Diagn Lab Immunol. 2005 Dec;12(12):1393-400 - PubMed
  46. West Afr J Med. 2002 Apr-Jun;21(2):138-41 - PubMed

Publication Types